Globe LifeFRA:TMJ +1.08%85 EBITDA Margin % is 23.46% as of Mar. 2026, which is 4% above its 10-year median of 22.63. GuruFocus rates FRA:TMJ with a GF Score™ of 85/100 and a GF Value™ of €127.64 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 371 Insurance companies, Globe Life ranks better than 77.09% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Globe Life's EBITDA for the
three
months ended in Mar. 2026 was €316 Mil. Globe Life's Revenue for the
three
months ended in Mar. 2026 was €1,349 Mil. Therefore, Globe Life's EBITDA margin for the quarter that ended in Mar. 2026 was 23.46%.
Globe Life (FRA:TMJ) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Globe Life EBITDA Margin % Related Terms
Globe Life EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Globe Life's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:TMJ vs UNM, PRI, JXN: EBITDA Margin % Comparison
For the Insurance - Life subindustry, Globe Life's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globe Life EBITDA Margin % vs Insurance Industry
For the Insurance industry and Financial Services sector, Globe Life's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Globe Life's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globe Life (FRA:TMJ) has a EBITDA Margin % of 23.46% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Globe Life and its competitors. This is near median its historical median of 22.63. Over the past decade, Globe Life's EBITDA Margin % has ranged from 20.75 to 26.52. According to the industry distribution chart, Globe Life ranks #85 out of 371 companies in the Insurance industry, placing it in the top 22.9%.
Is Globe Life's EBITDA Margin % too high?
Globe Life's current EBITDA Margin % of 23.46% is near median its 10-year median of 22.63. Over the past 10 years, this metric has ranged from a low of 20.75 to a high of 26.52. The Insurance industry median EBITDA Margin % is 14.91. Globe Life's value of 23.46% is 57.3% above this industry median. Based on the distribution chart, Globe Life ranks #85 out of 371 companies in the Insurance industry, which is in the top quartile — a strong position relative to peers. Overall, Globe Life has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Globe Life's EBITDA Margin % compare to UNM and PRI?
According to the Insurance industry distribution chart, Globe Life ranks #85 out of 371 companies for EBITDA Margin %. This places Globe Life in the top 23% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 14.91. Globe Life's value of 23.46% is 57.3% above this benchmark. Historically, Globe Life's own EBITDA Margin % has ranged from 20.75 to 26.52 over the past decade. While the company's 10-year median is 22.63 vs. the industry median of 14.91, Globe Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Insurance company?
The median EBITDA Margin % among Insurance companies is 14.91, based on 371 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globe Life's current EBITDA Margin % of 23.46% is 57.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Globe Life and its competitors. For the Insurance industry, the median EBITDA Margin % is 14.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globe Life's current EBITDA Margin % is 23.46%, which is near median its own 10-year median of 22.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globe Life stock overvalued right now?
Based on GuruFocus' analysis, Globe Life (FRA:TMJ) is currently considered Modestly Overvalued. The stock's GF Value™ is €127.64, compared to a current price of €149.80 — trading 17.4% above its estimated fair value. The current EBITDA Margin % is 23.46%, which is near median its 10-year median of 22.63 and 57.3% above the Insurance industry median of 14.91. Globe Life's overall GF Score™ is 85/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Globe Life (FRA:TMJ), the current EBITDA Margin % is 23.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globe Life (FRA:TMJ) Overvalued in 2026?
Based on GuruFocus' analysis, Globe Life stock appears to be overvalued.
The current stock price of €149.80 is trading 17.4% above its estimated GF Value™ of €127.64.
GuruFocus considers Globe Life to be Modestly Overvalued.
Key valuation signals for FRA:TMJ:
EBITDA Margin %: 23.46% (near median its 10-year median of 22.63)
GF Value™: €127.64 vs. price of €149.80 (17.4% above fair value)
Industry Position: 57.3% above the Insurance median (#85 of 371)
No single metric tells the full story. See the FRA:TMJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
85GF Score
Get the complete analysis for FRA:TMJ
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TMJ has been successfully added to your 
